SCHEMBL733019

SCHEMBL733019

[c]1cc(-c2ccccc2)nc(-c2nnn[nH]2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 3/20 0.39
CYP1A2 P05177 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
POLB P06746 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
ALDH1A1 P00352 3/20 0.33
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CGAS Q8N884 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
CYP3A4 P08684 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730958 0.86 RAB9A (0.33) MEN1KMT2ARAB9AL3MBTL1ALDH1A1
SCHEMBL732981 0.82 IDO1 (0.40) MEN1KMT2ARAB9AMAPTKDM4E
SCHEMBL733059 0.82 NPC1 (0.40) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL731571 0.79 NR1H2 (0.44) RAB9ANR1H2NR1H3ADORA2AADORA1
SCHEMBL731569 0.79 F2RL3 (0.34) MEN1KMT2ARAB9AALDH1A1ADORA2A
SCHEMBL730987 0.79 SCN5A (0.40) RAB9ACYP1A2ALDH1A1ADORA2AMAPT
SCHEMBL730964 0.78 DCUN1D1 (0.38) KMT2ARAB9AL3MBTL1ALDH1A1DCUN1D1
Water SCHEMBL7382263 0.78 NR1H2 (0.42) MEN1KMT2ARAB9ACYP1A2L3MBTL1
SCHEMBL732423 0.78 MEN1 (0.62) MEN1KMT2ARAB9AL3MBTL1ALDH1A1
SCHEMBL731210 0.77 CTSS (0.41) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 MEN1 2567/4885KMT2A 3686/4885RAB9A 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.